在帕金森病的亚thalamic刺激中对生活质量的分层化结果
Alexandra Gronostay1, Stefanie Theresa Jost1, Monty Silverdale2
1Department of Neurology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Journal of neurology, neurosurgery, and psychiatry
|December 21, 2023
概括
非运动性症状负担分层有效地预测了帕金森病 (PD) 的亚thalamic核深脑刺激 (STN-DBS) 后的生活质量 (QoL) 的改善. 这种方法优化了患者的选择,以获得更好的结果.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 生活质量研究 研究 生命质量研究
背景情况:
- 脑下核深度大脑刺激 (STN-DBS) 改善了帕金森病 (PD) 患者的结果.
- 很大一部分患者在STN-DBS后没有获得临床相关的生活质量 (QoL) 的改善.
- 需要对QoL结果进行个性化预测.
研究的目的:
- 开发和验证一个分层分析来预测STN-DBS后手术后的QoL改善.
- 评估手术前非运动负担,运动进展和利沃多巴反应对 QoL 结果的影响.
主要方法:
- 展望性,开放标签,多中心国际研究,随访6个月.
- 基于非运动症状尺度 (NMS),霍恩和雅尔尺度以及利沃多巴反应的分层.
- 在各层之间比较QOL响应 (PD问卷-8总结指数).
主要成果:
- 只有80/161名患者根据临床上有意义的门被归类为 QoL 响应者.
- 非运动分层显示,QoL不响应的绝对风险降低率 (23%) 是最大的.
- 非运动分层显著降低了 QoL 结果的分层内变化.
结论:
- 非运动性症状负担分层在临床上是有用的,并且在PD中STN-DBS后预测术后的QoL在统计上是可行的.
- 运动进展和勒沃多巴反应分层在预测QOL结果方面效率较低.
- 术前非运动性评估对于优化STN-DBS指示和QoL结果至关重要.
关键词:
帕金森氏症是什么?相关概念视频
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554


